Virginia Athena Triant, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 55 | 2023 | 16718 | 3.160 |
Why?
|
HIV | 10 | 2021 | 1604 | 1.190 |
Why?
|
Cardiovascular Diseases | 18 | 2022 | 15165 | 1.100 |
Why?
|
Anti-HIV Agents | 10 | 2021 | 4256 | 1.000 |
Why?
|
Epidemics | 2 | 2021 | 523 | 0.790 |
Why?
|
HIV Protease Inhibitors | 1 | 2020 | 430 | 0.600 |
Why?
|
Myocardial Infarction | 6 | 2022 | 11727 | 0.570 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 2148 | 0.560 |
Why?
|
Smoking Cessation | 2 | 2020 | 2071 | 0.550 |
Why?
|
CD4 Lymphocyte Count | 6 | 2019 | 2559 | 0.520 |
Why?
|
Stroke | 4 | 2020 | 9981 | 0.510 |
Why?
|
Behavior Therapy | 1 | 2020 | 865 | 0.490 |
Why?
|
Anti-Retroviral Agents | 5 | 2020 | 1715 | 0.480 |
Why?
|
Risk Factors | 34 | 2023 | 72290 | 0.450 |
Why?
|
Atherosclerosis | 3 | 2017 | 3445 | 0.430 |
Why?
|
Smoking | 4 | 2021 | 8987 | 0.430 |
Why?
|
Secondary Prevention | 1 | 2018 | 1530 | 0.410 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1125 | 0.410 |
Why?
|
Cell Adhesion Molecules | 1 | 2018 | 1602 | 0.410 |
Why?
|
Carotid Artery Diseases | 4 | 2021 | 882 | 0.390 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2278 | 0.360 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.340 |
Why?
|
Viral Load | 8 | 2019 | 3299 | 0.320 |
Why?
|
Coronary Disease | 2 | 2014 | 6077 | 0.310 |
Why?
|
Brain Ischemia | 1 | 2020 | 3265 | 0.280 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 294 | 0.280 |
Why?
|
HIV Long-Term Survivors | 2 | 2019 | 126 | 0.270 |
Why?
|
Humans | 72 | 2024 | 744343 | 0.270 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4456 | 0.270 |
Why?
|
Middle Aged | 42 | 2022 | 213383 | 0.260 |
Why?
|
Africa South of the Sahara | 2 | 2017 | 724 | 0.250 |
Why?
|
Risk Assessment | 10 | 2021 | 23338 | 0.240 |
Why?
|
Hospitalization | 5 | 2021 | 10262 | 0.230 |
Why?
|
Cerebral Hemorrhage | 1 | 2014 | 2647 | 0.220 |
Why?
|
Subacute Care | 2 | 2023 | 168 | 0.220 |
Why?
|
Adult | 29 | 2023 | 214055 | 0.210 |
Why?
|
Male | 40 | 2024 | 350118 | 0.200 |
Why?
|
Skin Diseases, Viral | 1 | 2021 | 21 | 0.200 |
Why?
|
Botswana | 3 | 2023 | 1040 | 0.200 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.200 |
Why?
|
Mass Screening | 1 | 2017 | 5255 | 0.190 |
Why?
|
Incidence | 8 | 2021 | 20947 | 0.190 |
Why?
|
Female | 42 | 2023 | 380194 | 0.190 |
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 1541 | 0.190 |
Why?
|
Purpura | 1 | 2021 | 122 | 0.180 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.180 |
Why?
|
Hepatitis C | 2 | 2022 | 1591 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2022 | 612 | 0.180 |
Why?
|
Case Management | 1 | 2021 | 286 | 0.180 |
Why?
|
Pressure Ulcer | 1 | 2021 | 155 | 0.180 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3778 | 0.170 |
Why?
|
Cohort Studies | 12 | 2021 | 40561 | 0.170 |
Why?
|
Heart Failure | 7 | 2020 | 10900 | 0.170 |
Why?
|
New York City | 1 | 2021 | 710 | 0.170 |
Why?
|
Patient Discharge | 2 | 2023 | 3313 | 0.160 |
Why?
|
Inpatients | 2 | 2020 | 2518 | 0.160 |
Why?
|
Urban Health | 1 | 2021 | 547 | 0.160 |
Why?
|
Antigens, CD | 3 | 2018 | 4026 | 0.160 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2018 | 1873 | 0.160 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2866 | 0.160 |
Why?
|
Decision Support Techniques | 2 | 2018 | 1956 | 0.150 |
Why?
|
Aged | 22 | 2022 | 163280 | 0.140 |
Why?
|
Adipose Tissue | 2 | 2020 | 3279 | 0.140 |
Why?
|
Myocardium | 2 | 2020 | 4776 | 0.140 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.140 |
Why?
|
Fractures, Bone | 1 | 2008 | 1947 | 0.140 |
Why?
|
Uganda | 5 | 2021 | 1243 | 0.140 |
Why?
|
Viral Nonstructural Proteins | 1 | 2018 | 241 | 0.140 |
Why?
|
Accidental Falls | 1 | 2024 | 1062 | 0.140 |
Why?
|
Case-Control Studies | 5 | 2021 | 21746 | 0.130 |
Why?
|
E-Selectin | 1 | 2018 | 579 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 889 | 0.130 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 707 | 0.130 |
Why?
|
Obesity | 5 | 2022 | 12745 | 0.130 |
Why?
|
Nitrates | 1 | 2016 | 265 | 0.130 |
Why?
|
Disease Management | 2 | 2017 | 2459 | 0.130 |
Why?
|
Risk | 2 | 2017 | 9687 | 0.120 |
Why?
|
Hepacivirus | 2 | 2022 | 1379 | 0.120 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.120 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1049 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 2018 | 791 | 0.120 |
Why?
|
Arteritis | 1 | 2016 | 159 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1155 | 0.120 |
Why?
|
Aftercare | 1 | 2020 | 866 | 0.120 |
Why?
|
United States | 10 | 2022 | 69872 | 0.120 |
Why?
|
Risk Management | 1 | 2017 | 571 | 0.120 |
Why?
|
Coronary Artery Disease | 4 | 2020 | 6487 | 0.120 |
Why?
|
Monocytes | 2 | 2020 | 2596 | 0.120 |
Why?
|
Patient Readmission | 4 | 2023 | 3114 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 667 | 0.110 |
Why?
|
Fibrosis | 1 | 2020 | 2029 | 0.110 |
Why?
|
Drug Resistance, Viral | 1 | 2018 | 820 | 0.110 |
Why?
|
Interleukin-6 | 2 | 2022 | 3200 | 0.100 |
Why?
|
American Heart Association | 1 | 2017 | 1056 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40075 | 0.100 |
Why?
|
Diazepam | 1 | 2013 | 205 | 0.100 |
Why?
|
Buprenorphine | 1 | 2020 | 640 | 0.100 |
Why?
|
Drug Interactions | 1 | 2016 | 1460 | 0.100 |
Why?
|
Triglycerides | 1 | 2019 | 2454 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13989 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2017 | 789 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2017 | 575 | 0.100 |
Why?
|
Hypertension | 3 | 2023 | 8480 | 0.100 |
Why?
|
Inflammation | 3 | 2016 | 10638 | 0.100 |
Why?
|
Comorbidity | 4 | 2020 | 10388 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.100 |
Why?
|
Length of Stay | 2 | 2023 | 6309 | 0.100 |
Why?
|
Midazolam | 1 | 2013 | 270 | 0.100 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1912 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 818 | 0.090 |
Why?
|
Tobacco Use Disorder | 1 | 2016 | 688 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 944 | 0.090 |
Why?
|
Aging | 4 | 2022 | 8664 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2024 | 57776 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1518 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2022 | 2987 | 0.090 |
Why?
|
Heart | 2 | 2020 | 4467 | 0.090 |
Why?
|
Anesthetics, Intravenous | 1 | 2013 | 417 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 979 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2014 | 867 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
Hypoglycemia | 1 | 2015 | 861 | 0.080 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5319 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 25043 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 880 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2020 | 1519 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2232 | 0.080 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 522 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 5751 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2073 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
Medical Informatics | 1 | 2014 | 745 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
Blood Pressure | 2 | 2023 | 8554 | 0.070 |
Why?
|
HIV-1 | 3 | 2019 | 6939 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7785 | 0.070 |
Why?
|
Young Adult | 5 | 2018 | 56430 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.070 |
Why?
|
Adolescent | 5 | 2018 | 85781 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2065 | 0.060 |
Why?
|
Colonoscopy | 1 | 2013 | 1367 | 0.060 |
Why?
|
Sex Factors | 2 | 2018 | 10397 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2020 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2022 | 63114 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.060 |
Why?
|
Calcinosis | 1 | 2012 | 1499 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Electronic Health Records | 2 | 2020 | 4468 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.050 |
Why?
|
Asthma | 1 | 2020 | 6011 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5524 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4599 | 0.050 |
Why?
|
Blood Sedimentation | 1 | 2022 | 231 | 0.050 |
Why?
|
Age Distribution | 1 | 2007 | 2902 | 0.050 |
Why?
|
Logistic Models | 2 | 2020 | 13408 | 0.050 |
Why?
|
Prone Position | 1 | 2021 | 194 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12354 | 0.040 |
Why?
|
Government Programs | 1 | 2022 | 275 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 426 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2021 | 499 | 0.040 |
Why?
|
Chronic Disease | 1 | 2014 | 9146 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7149 | 0.040 |
Why?
|
Cause of Death | 2 | 2019 | 3584 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2022 | 1588 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18370 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.040 |
Why?
|
Registries | 2 | 2014 | 8089 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12072 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6773 | 0.040 |
Why?
|
Models, Statistical | 1 | 2011 | 5102 | 0.040 |
Why?
|
Hospitals, General | 1 | 2020 | 749 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11725 | 0.040 |
Why?
|
Health Facilities | 1 | 2021 | 573 | 0.040 |
Why?
|
Causality | 1 | 2022 | 1275 | 0.030 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 404 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1401 | 0.030 |
Why?
|
Stroke Volume | 2 | 2019 | 5007 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 814 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 5987 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12245 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 2019 | 460 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
Biostatistics | 1 | 2016 | 162 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
Cognition | 2 | 2023 | 6770 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2018 | 952 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13881 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2902 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1364 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14722 | 0.030 |
Why?
|
Treatment Failure | 1 | 2018 | 2618 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13284 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1782 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1025 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2759 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3760 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20822 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 537 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1440 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4186 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 19905 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2401 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2015 | 849 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.020 |
Why?
|
Angiography | 1 | 2012 | 1639 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3670 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5317 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2864 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53288 | 0.020 |
Why?
|
Rural Population | 1 | 2016 | 2210 | 0.020 |
Why?
|
Language | 1 | 2014 | 1471 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3674 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35421 | 0.010 |
Why?
|
Infant | 1 | 2022 | 35136 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7322 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Primary Health Care | 1 | 2015 | 4558 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20129 | 0.010 |
Why?
|